Skip to main content

Table 3 Patient diagnosis and treatment characteristics

From: Impact of cancer and chemotherapy on autonomic nervous system function and cardiovascular reactivity in young adults with cancer: a case-controlled feasibility study

Cancer types

Treatment protocol (# of patients)

Breast

4 cycles FEC + Paclitaxel (n = 1)

4 cycles AC (n = 4)

Gastrointestinal

 

Pancreatic

FOLFIRINOX x 3 + Gemcitabine x 1 (n = 1)

Colon

Xelox x 4 (n = 1)

Anal

Mitomycin C + 5 FU x 4 (n = 1)

Hematological

 

Hodgkin’s Lymphoma

ABVD (n = 2)

Non-Hodgkin’s Lymphoma

R-CHOP (n = 1)

Other

 

Adenocarcinoma (unknown origin)

C-Pacli (n = 1)

Parotid (acinic cell carcinoma)

C-Pacli (n = 1)

  1. FEC fluorouracil epirubicin cyclophosphamide, AC adriamycin cyclophosphamide, FOLFIRINOX, folinic acid fluorouracil irinotecan oxaliplatin, 5 FU fluorouracil, ABVD adriamycin bleomycin vinblastine dacarbazine, R-CHOP rituximab + cyclophosphamide hydroxyldaunoreubicin oncovin (vincristine) prednisone, C-Pacli carboplatin + paclitaxel